<DOC>
	<DOCNO>NCT00003154</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Phase II trial study effectiveness aminocamptothecin treat patient stage III stage IV non-small cell lung cancer .</brief_summary>
	<brief_title>Chemotherapy Treating Patients With Advanced Non-small Cell Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine whether aminocamptothecin colloidal dispersion ( AC/CD ) administer 120 hour weekly infusion effective treatment advance non-small cell lung cancer . II . Observe toxicity associate treatment patient population . OUTLINE : Patients receive 120 hour continuous infusion aminocamptothecin colloidal dispersion ( AC/CD ) week 2 week , follow 1 week rest . Patients assess every 2 course therapy . Treatment aminocamptothecin continue indefinitely tumor shrinkage stable disease significant toxicity experience . Patients follow every 3 month . PROJECTED ACCRUAL : A total 19-36 patient accrue study .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm measurable stage IIIB IV nonsmall cell lung cancer No brain metastasis PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 Life expectancy : At least 12 week Hematopoietic : WBC least 3500/mm3 Granulocyte count least 1,500/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin great 1.5 mg/dL SGOT SGPT great 2.5 time upper limit normal ( ULN ) Alkaline phosphatase great 2.5 time ULN Renal : Creatinine great 1.5 mg/dL Creatinine clearance least 60 mL/min Calcium electrolytes normal Other : No malignancy within past 5 year except curatively treat nonmelanoma skin cancer carcinoma situ cervix Not pregnant nursing No active infection serious medical condition PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy Endocrine therapy : Not specify Radiotherapy : At least 2 week since prior radiotherapy No prior radiotherapy site ( ) measurable disease Surgery : At least 3 week since prior surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
	<keyword>stage IV non-small cell lung cancer</keyword>
</DOC>